85-1436-41 [取扱停止]HIV-1 nef, Recombinant, aa3-190, 20kD (Human Immunodeficiency Virus-1) 100ug H6004-13B
特徴
- The E. coli derived 20kD recombinant protein is a non-glycosylated polypeptide chain, containing the HIV-1 p24 gag immunodominant regions, aa3-190. Recombinant HIV nef is fused to beta-galactosidase (114kD).
- Specificity:Recognizes all sera of HIV-I infected individuals.
- Applications:Suitable for us in ELISA, Western Blot and an excellent antigen for early detection of HIV seroconvertors with minimal specificity problems. Other applications not tested.
- Storage and Stability:For long-term storage, aliquot and store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
- Size:100ug
- Source Antigen:Recombinant, E. coli
- Grade:Highly Purified
- Purity:≥ 95% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain. Chromatographically purified.
- Form:Supplied as a liquid in 0.01M sodium bicarbonate, 0.01M Na3EDTA, 0.014M B-me
- Specificity:Recognizes all sera of HIV-I infected individuals.
- EU Commodity Code:30021019
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





